Gene · 2696
GIPR: gastric inhibitory polypeptide receptor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GIPR: gastric inhibitory polypeptide receptor. Genes, record 2696. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2696
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P48546 | Gastric inhibitory polypeptide receptor | 466 | 13 | Ensembl, GeneID, HGNC |
Source UniProt
Patents132
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4777830 A1 | 2026-07-22 | 10 | P48546 | Espacenet |
| JP 2026518415 A | 2026-06-08 | 1 | P48546 | Espacenet |
| EP 4750795 A1 | 2026-06-03 | 220 | P48546 | Espacenet |
| JP 2026048788 A | 2026-03-17 | 3141 | P48546 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 47386 | P48546 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 47388 | P48546 | Espacenet |
| KR 1020250175337 A | 2025-12-16 | 1 | P48546 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 17754 | P48546 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 3508 | P48546 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 21958 | P48546 | Espacenet |
1 to 10 of 132
See all 132 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials176
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT07605247 | TIRZEPATIDE | PHASE2 | ClinicalTrials.gov | |
| NCT07602699 | TIRZEPATIDE | PHASE2 | ClinicalTrials.gov | |
| NCT07589322 | TIRZEPATIDE | ClinicalTrials.gov | ||
| NCT07588984 | TIRZEPATIDE | ClinicalTrials.gov | ||
| NCT07588438 | TIRZEPATIDE | PHASE4 | ClinicalTrials.gov | |
| NCT07574723 | TIRZEPATIDE | ClinicalTrials.gov | ||
| NCT07573163 | TIRZEPATIDE | PHASE2 | ClinicalTrials.gov | |
| NCT07567378 | TIRZEPATIDE | ClinicalTrials.gov | ||
| NCT07557355 | TIRZEPATIDE | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT07555730 | TIRZEPATIDE | PHASE4 | ClinicalTrials.gov |
1 to 10 of 176
See all 176 trialsNIH grants1,100
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GIPR papers | Newest fiscal year |
|---|---|---|---|
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 12 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 9 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 9 | 2025 |
| R01DK093757 | Genetic epidemiology of rare and regulatory variants for metabolic traits | 8 | 2025 |
| P30DK020595 | Diabetes Research and Training Center | 7 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 7 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 7 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 6 | 2025 |
| P30DK017047 | Diabetes Research Center | 5 | 2025 |
| T32HL007055 | Cardiovascular Epidemiology Training Grant | 5 | 2025 |
1 to 10 of 1,100Source NIH's project files
See all 1,100 nih grantsPapers1,380
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetically Proxied GIP-GIPR Pathway Perturbation and Fracture Risk. | Diabetes Obes Metab | 2026 | 42811415 | PubTator, text mining | PubMed |
| Skeletal Muscle Effects of GLP 1 Receptor Agonists: Molecular Mechanisms and Comparative Insights on Semaglutide and Tirzepatide, a Narrative Review. | Int J Mol Sci | 2026 | 42794486 | PubTator, text mining | PubMed |
| Genetic Assessment of Oesophageal Safety of GLP-1 and GIP Receptor Perturbation: A Drug-Target Mendelian Randomisation Study. | Biomedicines | 2026 | 42792631 | PubTator, text mining | PubMed |
| Genome-wide mapping of common and rare variant effects on adiposity across childhood. | Nat Genet | 2026 | 42791368 | PubTator, text mining | PubMed |
| Pulsatile liraglutide on a biased tirzepatide background: a hypothesis. | Front Endocrinol (Lausanne) | 2026 | 42787169 | PubTator, text mining | PubMed |
| GLP-1 receptor agonists and podocyte senescence in diabetic kidney disease: structural pharmacology, mechanistic evidence, and multi-receptor agonism. | Biochem Pharmacol | 2026 | 42777788 | PubTator, text mining | PubMed |
| AGA Clinical Practice Update on the Evaluation and Management of Metabolic Dysfunction- and Alcohol-Associated Liver Disease: Expert Review. | Clin Gastroenterol Hepatol | 2026 | 42776095 | PubTator, text mining | PubMed |
| The incretin-joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies. | Rheumatol Adv Pract | 2026 | 42774139 | PubTator, text mining | PubMed |
Effectiveness, Safety and Pharmacokinetics of BGM0504, a Dual GLP-1/GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. | Diabetes Obes Metab | 2026 | 42755112 | PubTator, text mining | PubMed |
| Redefining weight management after liver transplantation with glucagon-like peptide one and gastric inhibitory polypeptide receptor agonists. | World J Transplant | 2026 | 42751234 | PubTator, text mining | PubMed |
1 to 10 of 1,380
See all 1,380 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2696
GET https://conductscience.org/api/genes/v1/2696/patents?page=2